News

Novan Announces Late-Breaking Abstract Accepted for Presentation at American Academy of Dermatology’s (AAD) 2022 Annual Meeting

DURHAM, N.C., March 24, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that data…

2 years ago

PRIMED protects Canadians: PPE manufacturer reaches 100 million mask milestone at Cambridge manufacturing facility

CAMBRIDGE, Ontario, March 24, 2022 (GLOBE NEWSWIRE) -- PRIMED Medical Products (PRIMED) announces the production of 100 million masks at…

2 years ago

Celsion Corporation to Hold Year-End 2021 Financial Results and Business Update Conference Call on Thursday, March 31, 2022

LAWRENCEVILLE, N.J., March 24, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy and…

2 years ago

Revelation Biosciences Inc. Outlines Details on the Upcoming Data Analysis for Phase 2b Viral Challenge Study to Assess Efficacy of Intranasal REVTx 99a for the Prevention of H3N2 Influenza Infection

-Primary endpoint analysis expected early Q2 2022- -Final data expected Q2 2022- SAN DIEGO, March 24, 2022 (GLOBE NEWSWIRE) --…

2 years ago

Pure Extracts Reaches 36 Product SKU Listings Across Canada

VANCOUVER, British Columbia, March 24, 2022 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure…

2 years ago

Assure Announces Hiring of Two Senior Executives to Support Growth

Kelly Shelton Appointed Vice President of Sales and Sherri Wagner Named Vice President of Human ResourcesDENVER, March 24, 2022 (GLOBE…

2 years ago

SmileDirectClub Survey Reveals Growing Popularity and Acceptance of Telehealth

Consumers Believe one of the Greatest Benefits is the Elimination of Transportation - Especially as Fuel Costs Rise to Historic…

2 years ago

Predictive Oncology validates Discovery 21 proof-of-concept campaign

Predictive Oncology's Discovery 21 campaign evaluated the ability of its PeDAL® platform to make high-confidence predictions in ovarian tumor samples.…

2 years ago

SCYNEXIS to Report Fourth Quarter and Full Year 2021 Financial Results and Provide a Business Update

JERSEY CITY, N.J., March 24, 2022 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to…

2 years ago

Palisade Bio (Nasdaq: PALI) to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group and Hosted by M-Vest

CARLSBAD, Calif., March 24, 2022 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies…

2 years ago